Similarity between studies of dihydromyricetin and reservatrol for NAFLD
- PMID: 26318761
- DOI: 10.1016/j.phrs.2015.07.034
Similarity between studies of dihydromyricetin and reservatrol for NAFLD
Comment in
-
Response to letter to the Editor: "Similarity between studies of dihydromyricetin and resveratrol for NAFLD".Pharmacol Res. 2015 Oct;100:321. doi: 10.1016/j.phrs.2015.07.035. Epub 2015 Aug 20. Pharmacol Res. 2015. PMID: 26299475 No abstract available.
Comment on
-
Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.Dig Liver Dis. 2015 Mar;47(3):226-32. doi: 10.1016/j.dld.2014.11.015. Epub 2014 Dec 16. Dig Liver Dis. 2015. PMID: 25577300 Clinical Trial.
-
Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial.Pharmacol Res. 2015 Sep;99:74-81. doi: 10.1016/j.phrs.2015.05.009. Epub 2015 May 30. Pharmacol Res. 2015. PMID: 26032587 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical